Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
1.690
+0.100 (6.29%)
Nov 18, 2024, 4:00 PM EST - Market closed
Immix Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 18, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 46 | 137 | 32 | 47 | - | - |
| Market Cap Growth | -39.23% | 331.07% | -32.18% | - | - | - |
| Enterprise Value | 28 | 118 | 15 | 51 | - | - |
| Last Close Price | 1.69 | 6.92 | 2.29 | 3.56 | - | - |
| PB Ratio | 2.65 | 8.48 | 2.42 | 2.61 | - | - |
| P/TBV Ratio | 2.33 | 8.38 | 2.42 | 2.61 | - | - |
| Debt / Equity Ratio | 0.06 | - | - | 0.00 | -0.87 | -1.12 |
| Quick Ratio | 3.30 | 5.02 | 10.75 | 87.46 | 0.10 | 0.20 |
| Current Ratio | 3.47 | 5.32 | 11.70 | 90.01 | 0.10 | 0.20 |
| Return on Equity (ROE) | -118.50% | -106.22% | -52.84% | -367.80% | - | - |
| Return on Assets (ROA) | -60.54% | -57.92% | -31.04% | -9.02% | -38.27% | - |
| Return on Capital (ROIC) | -75.29% | -68.71% | -32.93% | -9.71% | - | - |
| Earnings Yield | -47.09% | -11.22% | -25.80% | -51.86% | - | - |
| FCF Yield | -35.45% | -8.31% | -23.23% | -3.38% | - | - |
| Buyback Yield / Dilution | -71.33% | -24.87% | -278.13% | -8.82% | - | - |
| Total Shareholder Return | -71.33% | -24.87% | -278.13% | -8.82% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.